ArticleTranslational cancer research2019
Which is better, EGFR-TKI mono or combination for non-small cell lung cancer with mutated EGFR?
Shigeru Tanzawa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it